Guided Therapeutics Revenue and Competitors

SpectRx, Inc. is a medical technology company providing innovative detection, monitoring and treatment solutions for the diabetes and non-invasive diagnostics healthcare markets. SpectRx is developing and will market the SimpleChoice™ line of innovative insulin delivery products for people with diabetes. These FDA-cleared products complement SpectRx’s consumer device for continuous glucose monitoring under development with Abbott Laboratories. SpectRx is also creating opportunities for its leading-edge biophotonic detection and monitoring technology, which uses light and spectral energies to create painless alternatives to blood-based and tissue-based procedures. Non-invasive products include a developmental non-invasive cervical cancer detection device. SpectRx also markets the BiliChek® Non-invasive Bilirubin Analyzer, a biophotonic, non-invasive, painless monitor for infant jaundice. For more information, visit SpectRx’s web site at www.spectrx.com.